Closed-loop Insulin Delivery Systems in Pancreatic Diabetes
Launched by CENTRE HOSPITALIER SUD FRANCILIEN · Jan 25, 2024
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
Secondary pancreatic diabetes is an unstable diabetes, due to deficiency in B cells which produce insulin, alpha cells which produce glucagon, and exorcrine insufficiency. Patients with secondary pancreatic diabetes are exposed to high glycemic variability and severe hypoglycemic episodes. Hybrid closed loop treatment has shown efficacy and safety for patients with type 1 diabetes and has the potential to improve the control of secondary pancreatic diabetes but has rarely been studied in this particular indication.
A retrospective observational cohort study in patients will be contucted su...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient
- • Presenting secondary pancreatic diabetes
- • Treatment with insulin closed-loop delivery
- Exclusion Criteria:
- • Patient who objected to the use of data
About Centre Hospitalier Sud Francilien
Centre Hospitalier Sud Francilien (CHSF) is a prominent healthcare institution located in the Île-de-France region, committed to advancing medical knowledge and improving patient care through innovative clinical research. As a sponsor of clinical trials, CHSF harnesses its state-of-the-art facilities and multidisciplinary expertise to conduct robust studies across various therapeutic areas. With a focus on patient safety and ethical standards, CHSF collaborates with leading researchers and healthcare professionals to explore new treatments and enhance clinical outcomes, ultimately contributing to the evolution of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Corbeil Essonnes, Fra, France
Patients applied
Trial Officials
Alfred PENFORNIS, PHD
Principal Investigator
Centre Hospitalier Sud Francilien
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported